Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Institutes of Health Clinical Center (CC)
Brigham and Women's Hospital
Essen Biotech
Azienda Ospedaliero-Universitaria di Parma
Memorial Sloan Kettering Cancer Center
University of Nebraska
Adela, Inc
Ohio State University Comprehensive Cancer Center
Mayo Clinic
Brigham and Women's Hospital
Incyte Corporation
University of Colorado, Denver
Azienda USL Reggio Emilia - IRCCS
University of Alabama at Birmingham
GlaxoSmithKline
University of Alberta
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Cedars-Sinai Medical Center
Universidade Federal de Pernambuco
Taproot Health
University of Modena and Reggio Emilia
Sellas Life Sciences Group
University of Rochester
Stanford University
Cedars-Sinai Medical Center
Sanguine Biosciences
Cancer Support Community, Research and Training Institute, Philadelphia
OHSU Knight Cancer Institute
Scripps Health
Celgene
Peking Union Medical College Hospital
Celgene
GlaxoSmithKline
Roswell Park Cancer Institute
Jonsson Comprehensive Cancer Center
Masonic Cancer Center, University of Minnesota
Celgene
Massachusetts General Hospital
InSightec
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
University of Wisconsin, Madison
LEO Pharma
Shenzhen BinDeBio Ltd.
AbbVie
Vanderbilt-Ingram Cancer Center
Fred Hutchinson Cancer Center